Jimmy Van den Eynden

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 32

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

PLoS genetics

Nature genetics

Cancer research

Universiteit Gent

Katholieke Universiteit Leuven (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universiteit Gent Oct 01 2018

Belgium

Assistant professor :: Human Structure and Repair

Göteborgs universitet Sahlgrenska Akademin Aug 21 2017 - Dec 31 2019

Sweden

Staff Scientist :: Department of Medical Biochemistry and Cell Biology

Artevelde Hogeschool Oct 01 2010 - Aug 31 2018

Belgium

Lecturer

Wetenschappelijk Instituut Volksgezondheid Feb 01 2017 - Aug 21 2017

Belgium

Senior Scientist Public Helath Genomics :: Public Health and Surveillance

Göteborgs universitet Sahlgrenska Akademin Apr 07 2015 - Feb 28 2017

Sweden

Postdoctoral researcher :: Department of Medical Biochemistry and Cell Biology

Universiteit Gent Sep 15 2013 - Apr 30 2015

Belgium

Postdoctoral researcher :: Dpt. of Plant Biotechnology and Bio-informatics and Dpt. of Information Technology

Stichting kankerregister Nov 01 2009 - Aug 31 2012

Belgium

Project Manager Belgian Virtual Tumourbank

Universiteit Hasselt Sep 15 2004 - Dec 31 2009

Belgium

PhD Student

Education History

Katholieke Universiteit Leuven - Sep 13 2013

Belgium

MSC :: Bioscience engineering

Universiteit Hasselt - Mar 22 2010

Belgium

PHD :: Biomedical Sciences

Katholieke Universiteit Leuven - Jun 26 2003

Belgium

PHD :: Medicine

Publications

Jesse Demuytere, Charlotte Carlier, Tom Van Helden, Joke Belza, Frank Vanhaecke, Feifan Xie, An Vermeulen, Joseph Weerts, Jürgen Thomale, Hannelore Denys, Philippe Tummers, Olivier Van Kerschaver, Wouter Willaert, Sarah Cosyns, Peter Merseburger, Arne Claeys, Jimmy Van den Eynden, Wim P Ceelen
Effects of hyperthermia on cisplatin tissue penetration and gene expression in peritoneal metastases: results from a randomized trial in ovarian cancer. The British journal of surgery 111 (4) (2024)
Jesse Demuytere, Charlotte Carlier, Tom Van Helden, Joke Belza, Frank Vanhaecke, Feifan Xie, An Vermeulen, Joseph Weerts, Jürgen Thomale, Hannelore Denys, Philippe Tummers, Olivier Van Kerschaver, Wouter Willaert, Sarah Cosyns, Peter Merseburger, Arne Claeys, Jimmy Van den Eynden, Wim P Ceelen
Effects of hyperthermia on cisplatin tissue penetration and gene expression in peritoneal metastases: results from a randomized trial in ovarian cancer. The British journal of surgery 111 (4) (2024)
Jonatan L Gabre, Peter Merseburger, Arne Claeys, Joachim Tetteh Siaw, Sarah-Lee Bekaert, Frank Speleman, Bengt Hallberg, Ruth H Palmer, Jimmy Van den Eynden
Preclinical exploration of the DNA damage response pathway using the interactive neuroblastoma cell line explorer CLEAN. NAR cancer 6 (1) (2024)
Jonatan L Gabre, Peter Merseburger, Arne Claeys, Joachim Tetteh Siaw, Sarah-Lee Bekaert, Frank Speleman, Bengt Hallberg, Ruth H Palmer, Jimmy Van den Eynden
Preclinical exploration of the DNA damage response pathway using the interactive neuroblastoma cell line explorer CLEAN. NAR cancer 6 (1) (2024)
Jimmy Van den Eynden
A systematic analysis of immune escape signals in the primary and metastatic tumor genome. Nature genetics 55 (5) (2023)
Arne Claeys, Jimmy Van den Eynden
Quantification of Neoantigen-Mediated Immunoediting in Cancer Evolution-Letter. Cancer research 83 (6) (2023)
Jimmy Van den Eynden
A systematic analysis of immune escape signals in the primary and metastatic tumor genome. Nature genetics 55 (5) (2023)
Marcus Borenäs, Ganesh Umapathy, Dan Emil Lind, Wei-Yun Lai, Jikui Guan, Joel Johansson, Eva Jennische, Alexander Schmidt, Yeshwant Kurhe, Jonatan L Gabre, Agata Aniszewska, Anneli Strömberg, Mats Bemark, Michael N Hall, Jimmy Van den Eynden, Bengt Hallberg, Ruth H Palmer
ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition. Proceedings of the National Academy of Sciences of the United States of America 121 (1) (2023)
Tzu-Po Chuang, Wei-Yun Lai, Jonatan L Gabre, Dan E Lind, Ganesh Umapathy, Abdulmalik A Bokhari, Bengt Bergman, Linnea Kristenson, Fredrik B Thorén, Anh Le, Robert C Doebele, Jimmy Van den Eynden, Ruth H Palmer, Bengt Hallberg
ALK fusion NSCLC oncogenes promote survival and inhibit NK cell responses via SERPINB4 expression. Proceedings of the National Academy of Sciences of the United States of America 120 (8) (2023)
Arne Claeys, Jimmy Van den Eynden
Quantification of Neoantigen-Mediated Immunoediting in Cancer Evolution-Letter. Cancer research 83 (6) (2023)
Tzu-Po Chuang, Wei-Yun Lai, Jonatan L Gabre, Dan E Lind, Ganesh Umapathy, Abdulmalik A Bokhari, Bengt Bergman, Linnea Kristenson, Fredrik B Thorén, Anh Le, Robert C Doebele, Jimmy Van den Eynden, Ruth H Palmer, Bengt Hallberg
ALK fusion NSCLC oncogenes promote survival and inhibit NK cell responses via SERPINB4 expression. Proceedings of the National Academy of Sciences of the United States of America 120 (8) (2023)
Tzu-Po Chuang, Wei-Yun Lai, Jonatan L Gabre, Dan E Lind, Ganesh Umapathy, Abdulmalik A Bokhari, Bengt Bergman, Linnea Kristenson, Fredrik B Thorén, Anh Le, Robert C Doebele, Jimmy Van den Eynden, Ruth H Palmer, Bengt Hallberg
ALK fusion NSCLC oncogenes promote survival and inhibit NK cell responses via SERPINB4 expression. Proceedings of the National Academy of Sciences of the United States of America 120 (8) (2023)
Marcus Borenäs, Ganesh Umapathy, Dan Emil Lind, Wei-Yun Lai, Jikui Guan, Joel Johansson, Eva Jennische, Alexander Schmidt, Yeshwant Kurhe, Jonatan L Gabre, Agata Aniszewska, Anneli Strömberg, Mats Bemark, Michael N Hall, Jimmy Van den Eynden, Bengt Hallberg, Ruth H Palmer
ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition. Proceedings of the National Academy of Sciences of the United States of America 121 (1) (2023)
Tzu-Po Chuang, Wei-Yun Lai, Jonatan L Gabre, Dan E Lind, Ganesh Umapathy, Abdulmalik A Bokhari, Bengt Bergman, Linnea Kristenson, Fredrik B Thorén, Anh Le, Robert C Doebele, Jimmy Van den Eynden, Ruth H Palmer, Bengt Hallberg
ALK fusion NSCLC oncogenes promote survival and inhibit NK cell responses via SERPINB4 expression. Proceedings of the National Academy of Sciences of the United States of America 120 (8) (2023)
Marcus Borenäs, Ganesh Umapathy, Dan Emil Lind, Wei-Yun Lai, Jikui Guan, Joel Johansson, Eva Jennische, Alexander Schmidt, Yeshwant Kurhe, Jonatan L Gabre, Agata Aniszewska, Anneli Strömberg, Mats Bemark, Michael N Hall, Jimmy Van den Eynden, Bengt Hallberg, Ruth H Palmer
ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition. Proceedings of the National Academy of Sciences of the United States of America 121 (1) (2023)
Tzu-Po Chuang, Wei-Yun Lai, Jonatan L Gabre, Dan E Lind, Ganesh Umapathy, Abdulmalik A Bokhari, Bengt Bergman, Linnea Kristenson, Fredrik B Thorén, Anh Le, Robert C Doebele, Jimmy Van den Eynden, Ruth H Palmer, Bengt Hallberg
ALK fusion NSCLC oncogenes promote survival and inhibit NK cell responses via SERPINB4 expression. Proceedings of the National Academy of Sciences of the United States of America 120 (8) (2023)
Jimmy Van den Eynden
A systematic analysis of immune escape signals in the primary and metastatic tumor genome. Nature genetics (2023)
Tzu-Po Chuang, Wei-Yun Lai, Jonatan L Gabre, Dan E Lind, Ganesh Umapathy, Abdulmalik A Bokhari, Bengt Bergman, Linnea Kristenson, Fredrik B Thorén, Anh Le, Robert C Doebele, Jimmy Van den Eynden, Ruth H Palmer, Bengt Hallberg
ALK fusion NSCLC oncogenes promote survival and inhibit NK cell responses via SERPINB4 expression. Proceedings of the National Academy of Sciences of the United States of America 120 (8) (2023)
Tzu-Po Chuang, Wei-Yun Lai, Jonatan L Gabre, Dan E Lind, Ganesh Umapathy, Abdulmalik A Bokhari, Bengt Bergman, Linnea Kristenson, Fredrik B Thorén, Anh Le, Robert C Doebele, Jimmy Van den Eynden, Ruth H Palmer, Bengt Hallberg
ALK fusion NSCLC oncogenes promote survival and inhibit NK cell responses via SERPINB4 expression. Proceedings of the National Academy of Sciences of the United States of America 120 (8) (2023)
Marcus Borenäs, Ganesh Umapathy, Dan Emil Lind, Wei-Yun Lai, Jikui Guan, Joel Johansson, Eva Jennische, Alexander Schmidt, Yeshwant Kurhe, Jonatan L Gabre, Agata Aniszewska, Anneli Strömberg, Mats Bemark, Michael N Hall, Jimmy Van den Eynden, Bengt Hallberg, Ruth H Palmer
ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition. Proceedings of the National Academy of Sciences of the United States of America 121 (1) (2023)
Louise de Schaetzen van Brienen, Giles Miclotte, Maarten Larmuseau, Jimmy Van den Eynden, Kathleen Marchal
Network-Based Analysis to Identify Drivers of Metastatic Prostate Cancer Using GoNetic. Cancers 13 (21) (2021)
Joanna Szydzik, Dan Emil Lind, Badrul Arefin, Yeshwant Kurhe, Ganesh Umapathy, Joachim Tetteh Siaw, Arne Claeys, Jonatan L Gabre, Jimmy Van den Eynden, Bengt Hallberg, Ruth H Palmer
ATR inhibition enables complete tumour regression in ALK-driven NB mouse models. Nature communications 12 (1) (2021)
Marcus Borenäs, Ganesh Umapathy, Wei-Yun Lai, Dan Emil Lind, Barbara Witek, Jikui Guan, Patricia Mendoza-García, Tafheem Masudi, Arne Claeys, Tzu-Po Chuang, Abeer El Wakil, Badrul Arefin, Susanne Fransson, Jan Koster, Mathias Johansson, Jennie Gaarder, Jimmy Van den Eynden, Bengt Hallberg, Ruth H Palmer
ALK ligand ALKAL2 potentiates MYCN-driven neuroblastoma in the absence of ALK mutation. The EMBO journal 40 (3) (2021)
Joachim T Siaw, Jonatan L Gabre, Ezgi Uçkun, Marc Vigny, Wancun Zhang, Jimmy Van den Eynden, Bengt Hallberg, Ruth H Palmer, Jikui Guan
Loss of RET Promotes Mesenchymal Identity in Neuroblastoma Cells. Cancers 13 (8) (2021)
Arne Claeys, Tom Luijts, Kathleen Marchal, Jimmy Van den Eynden
Low immunogenicity of common cancer hot spot mutations resulting in false immunogenic selection signals. PLoS genetics 17 (2) (2021)
Jimmy Van den Eynden, Alejandro Jiménez-Sánchez, Martin L Miller, Erik Larsson
Lack of detectable neoantigen depletion signals in the untreated cancer genome. Nature genetics 51 (12) (2019)
Jimmy Van den Eynden, Tine Descamps, Els Delporte, Nancy H C Roosens, Sigrid C J De Keersmaecker, Vanessa De Wit, Joris Robert Vermeesch, Els Goetghebeur, Jean Tafforeau, Stefaan Demarest, Marc Van den Bulcke, Herman Van Oyen
The genetic structure of the Belgian population. Human genomics 12 (1) (2018)
Jimmy Van den Eynden, Ganesh Umapathy, Arghavan Ashouri, Diana Cervantes-Madrid, Joanna Szydzik, Kristina Ruuth, Jan Koster, Erik Larsson, Jikui Guan, Ruth H Palmer, Bengt Hallberg
Phosphoproteome and gene expression profiling of ALK inhibition in neuroblastoma cell lines reveals conserved oncogenic pathways. Science signaling 11 (557) (2018)
Kerryn Elliott, Martin Boström, Stefan Filges, Markus Lindberg, Jimmy Van den Eynden, Anders Ståhlberg, Anders R Clausen, Erik Larsson Lekholm
Elevated pyrimidine dimer formation at distinct genomic bases underlies promoter mutation hotspots in UV-exposed cancers. PLoS genetics 14 (12) (2018)
Jikui Guan, Susanne Fransson, Joachim Tetteh Siaw, Diana Treis, Jimmy Van den Eynden, Damini Chand, Ganesh Umapathy, Kristina Ruuth, Petter Svenberg, Sandra Wessman, Alia Shamikh, Hans Jacobsson, Lena Gordon, Jakob Stenman, Pär-Johan Svensson, Magnus Hansson, Erik Larsson, Tommy Martinsson, Ruth H Palmer, Per Kogner, Bengt Hallberg
Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib. Cold Spring Harbor molecular case studies 4 (4) (2018)
Nils Johan Fredriksson, Kerryn Elliott, Stefan Filges, Jimmy Van den Eynden, Anders Ståhlberg, Erik Larsson Lekholm
Recurrent promoter mutations in melanoma are defined by an extended context-specific mutational signature. PLoS genetics 13 (5) (2017)
Jimmy Van den Eynden, Swaraj Basu, Erik Larsson
Somatic Mutation Patterns in Hemizygous Genomic Regions Unveil Purifying Selection during Tumor Evolution. PLoS genetics 12 (12) (2016)

Jimmy Van den Eynden.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jimmy Van den Eynden